Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of AZT + Clarithromycin combination (AIDS Initiative) M960122

CASRN: AZTCLARITHRO

Synonyms/Common Names

  • 3'-Azido-3'-deoxythymidine + clarithromycin combination
  • Clarithromycin + AZT combination

Secondary:

  • 30516-87-1 - 3'-Azido-3'-deoxythymidine (AIDS)
  • 30516-87-1 - AZT transplacental carcinogenesis study
  • 81103-11-9 - Clarithromycin

Special Studies

  • Toxicokinetic Study (Gavage)  (S0646)  Completed 
    • Male and Female Mice [M]: B6C3F1
    • Dose: (gavage) 3 mg/mL clarithro & 3 mg/mL clarithro + 15 mg/mL, AZT (PTKS doses) [M].

Organ Systems Toxicity

  • 10 to 30 days Repro/Dev Gen Tox (28-Day) (Gavage)  (RDGT96002)  Completed 
    • NIH Number: 04-4418
      Citation: NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Studies of 3'-Azido-3'-deoxythymidine (AZT) and Clarithromycin Combinations (CASRNs 30516-87-1 and 81103-11-9) Administered by Gavage to Swiss (CD-1®) Mice
    • Male and Female Mice: Swiss CD-1
    • Dose: 200 or 400 mg/kg AZT; 500, 1250, or 2500 mg clarithromycin.
  • 10 to 30 days Repro/Dev Gen Tox (28-Day) (Gavage)  (RDGT97001)  Completed 
    • NIH Number: 04-4418
      Citation: NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Studies of 3'-Azido-3'-deoxythymidine (AZT) and Clarithromycin Combinations (CASRNs 30516-87-1 and 81103-11-9) Administered by Gavage to Swiss (CD-1®) Mice
    • Male and Female Mice: Swiss CD-1
    • Dose: 200 or 400 mg AZT: 250, 500, or 1000 mg clarithromycin.